RRoche Read More Roche, Asahi Kasei, Verastem—Fierce Pharma Asia2026-11-22 Roche extended its China shopping spree with a $1 billion-plus obesity deal. Asahi Kasei’s Hovilpri became the first…
RRoche Read More Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer2026-10-28 Divarasib monotherapy demonstrated superior efficacy over first-generation KRAS G12C inhibitors, lowering the risk of disease progression or death…
RRoche Read More Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug2026-07-03 Roche RHHBY reported positive results from the late-stage Krascendo 1 study evaluating experimental candidate, divarasib, in patients with…
RRoche Read More Roche KRAS drug succeeds in head-to-head lung cancer study2026-07-02 This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…